• Mashup Score: 0

    September 21, 2022 — Medtronic announced today that it has received Food and Drug Administration (FDA) approval for the treatment of non-left main bifurcation lesions utilizing the provisional bifurcation stenting technique (using a single stent to treat the bifurcation) with the Onyx Frontier drug-eluting stent (DES) and the Resolute Onyx DES.1 This indication will allow Medtronic to provide a…

    Tweet Tweets with this article
    • @DAICeditor @Medtronic Medtronic received #FDA approval for the treatment of non-left main bifurcation lesions utilizing the provisional #bifurcation #stenting technique with the #OnyxFrontier drug-eluting stent (#DES) and the #ResoluteOnyxDES: https://t.co/0vJIKG2TYB

  • Mashup Score: 0

    Operadores:O. MendizC. FavaInstituto de Cardiología y Cirugía Cardiovascular del Hospital Universitario Fundación FavaloroSuscribite a mi canal: https://bit….

    Tweet Tweets with this article
    • Compartimos un caso d ATC a un TCI muy calcificado con #IVL #Cutting #IVUS y dos capas d #DES https://t.co/dIkj1aM7mz (los invito a suscribirse al canal) (heavily calcified #LM #PCI with all these tools) #imaging #radialfirst https://t.co/FS4LkgOk11

  • Mashup Score: 0

    May 27, 2022 — The SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained drug release, similar to a drug-eluting stent (DES). SELUTION SLR was also the first DEB granted “Breakthrough Device Designation” by the FDA on March 4, 2019 and further on September 25, 2019 for below-the-knee (BTK) indications in peripheral artery disease. “This…

    Tweet Tweets with this article
    • @DAICeditor The #SELUTION_SLR (Sustained Limus Release) is a novel #sirolimus_eluting_balloon that provides a controlled sustained drug release, similar to a #drug_eluting #stent (#DES): https://t.co/ow5ekF5PAz

  • Mashup Score: 0
    EuroIntervention - 2 year(s) ago

    The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

    Tweet Tweets with this article
    • NEW ISSUE: An expert consensus on STEMI networks; #TAVI outcomes in younger inoperable pts; #TEER in pts with mitral annulus calcification; temporal trends in outcomes after PCI; ticagrelor monotherapy and #DES type https://t.co/ScFQ46AfD6 @EuroInterventio @PCRonline #EAPCI https://t.co/RstqRfym0s